42972-46-3

Usage

Uses

Used in Pharmaceutical Industry:
Ethanone, 1-(5-methyl-3-pyridinyl)is used as an intermediate in the synthesis of various pharmaceuticals for its potential medicinal properties. It plays a crucial role in the development of new drugs, contributing to the advancement of medical treatments.
Used in Agrochemical Industry:
Ethanone, 1-(5-methyl-3-pyridinyl)is utilized as an intermediate in the production of agrochemicals, specifically in the synthesis of insecticides. Its unique properties make it a valuable component in creating effective pest control solutions.
Used in Dye Industry:
Ethanone, 1-(5-methyl-3-pyridinyl)is used as a building block in the synthesis of various dyes due to its aromatic properties. Its contribution to the development of new dyes enhances the range of color options available in the market.
Used in Perfume Industry:
Leveraging its unique aromatic properties, Ethanone, 1-(5-methyl-3-pyridinyl)- is used in the perfume industry as a key ingredient in the creation of various fragrances. It adds depth and complexity to scents, enriching the olfactory experience.
Used in Research and Development:
Ethanone, 1-(5-methyl-3-pyridinyl)is employed in research and development for its potential medicinal properties. Scientists and researchers explore its applications in the development of new drugs, further expanding its uses and significance in the scientific community.

Upstream product

• 3430-16-8 5-bromo-3-picoline 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 
• 78191-00-1 N-Methoxy-N-methylacetamide 
• 42885-14-3 5-cyano-3-methylpyridine 
• 75-16-1 methylmagnesium bromide 
• 342602-12-4 N-methoxy-N,5-dimethylnicotinamide 

Downstream Products

• 3222-49-9 5-methylnicotinic acid 
• 73591-81-8 5-methyl-1-(3,5-di-O-benzoyl-α-D-ribofuranosyl)-3-methoxycarbonylpyridinium chloride 
• 73591-81-8 5-methyl-1-(3,5-di-O-benzoyl-β-D-ribofuranosyl)-3-methoxycarbonylpyridinium chloride 
• 29681-45-6 5-methylnicotinic acid methyl ester 
• 73591-87-4 3-Acetyl-1-((2S,3R,4R,5R)-3,4-bis-benzoyloxy-5-benzoyloxymethyl-tetrahydro-furan-2-yl)-5-methyl-pyridinium; bromide 
• 73591-88-5 3-Acetyl-1-((2R,3R,4R,5R)-3,4-bis-benzoyloxy-5-benzoyloxymethyl-tetrahydro-furan-2-yl)-5-methyl-pyridinium; bromide 
• 73591-77-2 3-acetyl-5-methyl-1-(3,5-di-O-benzoyl-β-D-ribofuranosyl)pyridinium chloride 
• 73591-77-2 3-acetyl-5-methyl-1-(3,5-di-O-benzoyl-α-D-ribofuranosyl)pyridinium chloride 

Relevant academic research and scientific papers

Pyrimidinone Derivatives as Antimalarial Agents

The invention relates to novel pyrimidinone-based heterocyclic compounds which are parasite growth inhibitors, having the general formula (I) in which Y is a morpholine chosen from three bridged morpholines, L is a bond or a linker, n=0 or 1 and R2 is a methyl group when n=0 and a hydrogen atom when n=1. Process for the preparation thereof and therapeutic use thereof.

ISOXAZOLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to isoxazolopyndine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the isoxazolopyndine compounds described herein in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

PYRIMIDINONE DERIVATIVES AS ANTIMALARIAL AGENTS

The invention relates to novel pyrimidinone-based heterocyclic compounds which are parasite growth inhibitors, having the general formula (I) in which Y is a morpholine chosen from three bridged morpholines, L is a bond or a linker, n = 0 or 1 and R2 is a methyl group when n = 0 and a hydrogen atom when n = 1. Process for the preparation thereof and therapeutic use thereof.

COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFR and PDGFR kinases.

PYRIDAZIN-3 (2H) -ONE DERIVATIVES AND THEIR USE AS PDE4 INHIBITORS

New pyridazin-e-(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.